Stock listing
NASDAQ:KPTI Karyopharm Therapeutics Inc. Stock
Home listing (NASDAQ) of Karyopharm Therapeutics Inc.
Follow Karyopharm Therapeutics Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:KPTI
$0.055 USD -0.005 (-8.7%)
Close on Nov 6, 2026
- Day range
- $0.040 – $0.056 USDNov 6, 2026
- Volume
- 101.9M sharesNov 6, 2026
- Market cap
- —Left out: price × shares is far from the company's reported size
- 52-week range
- $0.040 – $10.990 USDLowest and highest trades, Nov 7, 2025 – Nov 6, 2026
- Traded on an average day
- $2.79M USDMedian day 1.36M shares · last 3 months, Aug 6, 2026 – Nov 6, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:KPTI · Home | $0.055 USD | -0.005 (-8.7%) | 101,890,161 | $0.048 | $0.056 | $0.040 | $0.060 | Close on Nov 6, 2026 |
| Frankfurt:25K0 | €0.041 EUR | -0.006 (-13.7%) | — | €0.050 | €0.050 | €0.041 | €0.048 | Close on Nov 6, 2026 |
Daily closes
Last 3 months, Aug 6, 2026 – Nov 6, 2026 · NASDAQ:KPTI · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.055 | -0.005 | -8.7% | $0.048 | $0.056 | $0.040 | 101,890,161 | |
| $0.060 | -0.013 | -17.6% | $0.054 | $0.064 | $0.050 | 18,847,981 | |
| $0.073 | -0.015 | -17.4% | $0.081 | $0.127 | $0.073 | 40,915,198 | |
| $0.088 | -0.024 | -21.2% | $0.110 | $0.110 | $0.082 | 16,868,112 | |
| $0.112 | -0.550 | -83.1% | $0.153 | $0.160 | $0.095 | 47,445,500 | |
| $0.662 | -0.218 | -24.8% | $0.902 | $0.902 | $0.584 | 3,523,400 | |
| $0.880 | +0.048 | +5.8% | $0.810 | $0.987 | $0.781 | 6,845,500 | |
| $0.832 | +0.352 | +73.3% | $0.456 | $0.909 | $0.456 | 55,288,000 | |
| $0.480 | -0.002 | -0.4% | $0.459 | $0.483 | $0.430 | 996,500 | |
| $0.482 | -0.036 | -6.9% | $0.508 | $0.517 | $0.422 | 1,364,800 | |
| $0.518 | -0.028 | -5.1% | $0.537 | $0.555 | $0.440 | 1,959,000 | |
| $0.546 | +0.122 | +28.8% | $0.437 | $0.553 | $0.422 | 7,488,500 | |
| $0.424 | +0.065 | +18.1% | $0.363 | $0.436 | $0.363 | 1,616,500 | |
| $0.359 | +0.013 | +3.8% | $0.340 | $0.389 | $0.340 | 763,800 | |
| $0.346 | -0.044 | -11.3% | $0.400 | $0.400 | $0.331 | 1,256,500 | |
| $0.390 | +0.039 | +11.1% | $0.351 | $0.400 | $0.330 | 2,707,000 | |
| $0.351 | +0.036 | +11.4% | $0.310 | $0.352 | $0.310 | 1,399,100 | |
| $0.315 | -0.112 | -26.2% | $0.427 | $0.427 | $0.315 | 2,075,500 | |
| $0.427 | -0.078 | -15.4% | $0.490 | $0.502 | $0.396 | 1,750,800 | |
| $0.505 | -0.100 | -16.5% | $0.594 | $0.605 | $0.502 | 895,100 | |
| $0.605 | +0.005 | +0.8% | $0.602 | $0.625 | $0.565 | 963,000 | |
| $0.600 | -0.045 | -7.0% | $0.630 | $0.644 | $0.600 | 870,200 | |
| $0.645 | -0.005 | -0.8% | $0.650 | $0.690 | $0.623 | 758,700 | |
| $0.650 | -0.021 | -3.1% | $0.691 | $0.715 | $0.635 | 1,176,200 | |
| $0.671 | -0.131 | -16.3% | $0.802 | $0.802 | $0.626 | 1,983,300 | |
| $0.802 | -0.065 | -7.5% | $0.857 | $0.894 | $0.747 | 2,336,700 | |
| $0.867 | -0.353 | -28.9% | $1.190 | $1.200 | $0.848 | 2,660,000 | |
| $1.220 | +0.015 | +1.2% | $1.260 | $1.270 | $1.180 | 1,754,300 | |
| $1.205 | -0.415 | -25.6% | $1.620 | $1.625 | $1.200 | 1,864,200 | |
| $1.620 | 0.000 | 0.0% | $1.590 | $1.660 | $1.540 | 326,500 | |
| $1.620 | -0.110 | -6.4% | $1.730 | $1.770 | $1.565 | 1,466,900 | |
| $1.730 | -0.020 | -1.1% | $1.730 | $1.770 | $1.710 | 677,300 | |
| $1.750 | -0.070 | -3.8% | $1.810 | $1.840 | $1.660 | 957,500 | |
| $1.820 | -0.040 | -2.2% | $1.870 | $1.920 | $1.780 | 986,800 | |
| $1.860 | -0.020 | -1.1% | $1.850 | $1.930 | $1.780 | 1,624,600 | |
| $1.880 | +0.090 | +5.0% | $1.770 | $1.885 | $1.670 | 1,900,600 | |
| $1.790 | +0.090 | +5.3% | $1.747 | $1.850 | $1.655 | 1,089,100 | |
| $1.700 | +0.160 | +10.4% | $1.540 | $1.720 | $1.540 | 1,353,800 | |
| $1.540 | -0.060 | -3.8% | $1.590 | $1.700 | $1.525 | 1,329,000 | |
| $1.600 | -0.010 | -0.6% | $1.550 | $1.620 | $1.550 | 991,400 | |
| $1.610 | -0.010 | -0.6% | $1.500 | $1.610 | $1.240 | 6,735,100 | |
| $1.620 | -0.070 | -4.1% | $1.680 | $1.680 | $1.595 | 800,500 | |
| $1.690 | -0.030 | -1.7% | $1.720 | $1.750 | $1.650 | 772,600 | |
| $1.720 | -0.070 | -3.9% | $1.770 | $1.790 | $1.700 | 1,007,000 | |
| $1.790 | +0.020 | +1.1% | $1.770 | $1.840 | $1.755 | 577,300 | |
| $1.770 | -0.020 | -1.1% | $1.790 | $1.806 | $1.720 | 818,700 | |
| $1.790 | -0.060 | -3.2% | $1.900 | $1.940 | $1.725 | 1,295,900 | |
| $1.850 | -0.210 | -10.2% | $2.020 | $2.065 | $1.840 | 1,598,000 | |
| $2.060 | +0.190 | +10.2% | $1.910 | $2.140 | $1.791 | 2,028,100 | |
| $1.870 | -0.070 | -3.6% | $1.980 | $1.990 | $1.860 | 823,500 | |
| $1.940 | -0.020 | -1.0% | $1.990 | $2.060 | $1.930 | 1,105,300 | |
| $1.960 | +0.040 | +2.1% | $1.920 | $1.990 | $1.860 | 753,800 | |
| $1.920 | +0.060 | +3.2% | $1.870 | $1.950 | $1.870 | 1,060,619 | |
| $1.860 | -0.100 | -5.1% | $1.950 | $1.960 | $1.830 | 845,772 | |
| $1.960 | +0.140 | +7.7% | $1.850 | $1.970 | $1.822 | 874,600 | |
| $1.820 | -0.180 | -9.0% | $2.000 | $2.000 | $1.820 | 865,600 | |
| $2.000 | +0.070 | +3.6% | $1.930 | $2.015 | $1.930 | 792,100 | |
| $1.930 | +0.120 | +6.6% | $1.880 | $1.960 | $1.820 | 1,145,200 | |
| $1.810 | -0.210 | -10.4% | $2.020 | $2.030 | $1.790 | 1,387,600 | |
| $2.020 | +0.030 | +1.5% | $1.970 | $2.060 | $1.970 | 886,900 | |
| $1.990 | -0.040 | -2.0% | $2.030 | $2.087 | $1.920 | 1,727,100 | |
| $2.030 | -0.070 | -3.3% | $2.100 | $2.149 | $2.000 | 1,836,800 | |
| $2.100 | +0.140 | +7.1% | $1.930 | $2.180 | $1.930 | 1,962,600 | |
| $1.960 | -0.160 | -7.5% | $2.140 | $2.179 | $1.915 | 1,795,700 | |
| $2.120 | +0.170 | +8.7% | $1.960 | $2.120 | $1.910 | 1,792,800 | |
| $1.950 | +0.040 | +2.1% | $1.880 | $2.005 | $1.880 | 1,189,100 |
- Ticker
- NASDAQ:KPTI
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 4, 2026
Karyopharm to Present Selinexor Data in Patients with Myelofibrosis and Multiple Myeloma at the 68th American Society of Hematology Annual Meeting and Exposition (ASH)
Latest earnings call · Aug 13, 2026
Karyopharm Therapeutics (NASDAQ:KPTI) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Aug 13, 2026
Q2 2026 Earnings Presentation
Earnings · 40 slides
Calls
Replays
Karyopharm Therapeutics (NASDAQ:KPTI) Q2 2026 Earnings Call
Thu, Aug 13, 2026 · 8:00 AM ET
Watch TranscriptKaryopharm Therapeutics (NASDAQ:KPTI) Q1 2026 Earnings Call
Thu, May 14, 2026 · 8:00 AM ET
Watch TranscriptKaryopharm Therapeutics (NASDAQ:KPTI) Q4 2025 Earnings Call
Thu, Feb 12, 2026 · 8:00 AM ET
Watch Transcript
Latest news
Karyopharm to Present Selinexor Data in Patients with Myelofibrosis and Multiple Myeloma at the 68th American Society of Hematology Annual Meeting and Exposition (ASH)
Nov 4, 2026
Closed $0.073 (-17.4%) on Nov 4, 2026
Karyopharm Therapeutics Inc. Announces Planned Merger with Ayrmid Ltd. to Strengthen Company for the Future
Nov 2, 2026
Closed $0.112 (-83.1%) on Nov 2, 2026
Karyopharm Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Oct 1, 2026
Closed $0.802 (-7.5%) on Oct 2, 2026
Karyopharm Submits Supplemental New Drug Application to the FDA for XPOVIO® (selinexor) Plus Ruxolitinib for Patients with Myelofibrosis
Aug 31, 2026
Closed $2.06 (+10.2%) on Aug 31, 2026
Karyopharm Reports Second Quarter 2026 Financial Results and Highlights Continued Progress Toward Myelofibrosis sNDA Submission
Aug 13, 2026
Closed $1.99 (-2.0%) on Aug 13, 2026
Karyopharm to Report Second Quarter 2026 Financial Results on August 13, 2026
Aug 10, 2026
Closed $1.96 (-7.5%) on Aug 10, 2026
Karyopharm Plans to Submit sNDA for Selinexor Plus Ruxolitinib in Myelofibrosis Under Accelerated Approval Pathway
Jul 30, 2026
Closed $1.92 (-72.6%) on Jul 31, 2026
Karyopharm Announces Topline Results from Phase 3 XPORT-EC-042 Trial in Endometrial Cancer
Jul 30, 2026
Closed $1.92 (-72.6%) on Jul 31, 2026
Karyopharm to Participate in Webcast Featuring Endometrial Cancer Key Opinion Leader on June 8, 2026
Jun 3, 2026
Closed $9.07 (+0.8%) on Jun 4, 2026
Financings
Private placement of common stock and accompanying warrants
Oct 8, 2025
Announced: about US$8.75M · Warrants at US$6.64
Use of proceeds: Transaction expenses and general corporate purposes, including ongoing and planned clinical trial activities
New term loan borrowings and new convertible notes
Oct 8, 2025
Announced: US$27.5M
Use of proceeds: Transaction expenses and general corporate purposes, including ongoing and planned clinical trial activities
Decks
Q2 2026 Earnings Presentation
Earnings · 40 slides · Aug 13, 2026
Investor Presentation (May 2026)
Investor deck · 59 slides · May 2026
Technical Presentation (March 2026)
Technical · 23 slides · Mar 24, 2026
Q4 2025 Earnings Presentation
Earnings · 35 slides · Feb 12, 2026
Karyopharm Therapeutics Inc. on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 24 in the last 12 months · 179 in all · newest Nov 4, 2026 · oldest 2019
- Calls
- 26 calls with a replay · 26 with a transcript · latest Aug 13, 2026
- Decks
- 30 decks · latest Aug 13, 2026
Where Karyopharm Therapeutics Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:KPTI · Home listing · This page | NASDAQ | United States | USD |
| LS Exchange:A40YLC | LS Exchange | Germany | EUR |
| Lang & Schwarz:A40YLC | Lang & Schwarz | Germany | EUR |
| gettex:25K0 | gettex | Germany | EUR |
| BX Swiss:KPTI | BX Swiss | Switzerland | CHF |
| Tradegate:25K0 | Tradegate | Germany | EUR |
| BOATS:KPTI | BOATS | United States | USD |
| Dusseldorf:25K0 | Dusseldorf | Germany | EUR |
| Frankfurt:25K0 | Frankfurt | Germany | EUR |
| Munich:25K0 | Munich | Germany | EUR |
| Stuttgart:25K0 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Karyopharm Therapeutics Inc.